Suchergebnisse - "SUBKLEWE MARION"

PubPharm (18)

1

T cells take aim in AML : targeting IDH2

enthalten in: Blood | 2024

von Subklewe, M.

2

Immune effector cell-associated hematotoxicity : EHA/EBMT consensus grading and best practice recommendations

enthalten in: Blood | 2023

von Rejeski, K. | Subklewe, M. | Aljurf, M. | +34

CommentIn: Blood. 2023 Sep 7;142(10):859-861. - PMID 37676695

3

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML

enthalten in: Blood | 2023

von Roas, M. | Vick, B. | Kasper, M. | +21

4

WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in mice

enthalten in: Blood | 2023

von Ghalandary, M. | Gao, Y. | Amend, D. | +11

5

Immune effector cell-associated hematotoxicity : EHA/EBMT consensus grading and best practice recommendations

enthalten in: Blood | September 7, 2023

von Rejeski, K. | Subklewe, M. | Aljurf, M. | +34

6

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL

enthalten in: Blood | 2022

von Rejeski, K. | Wu, Z. | Blumenberg, V. | +11

7

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals

enthalten in: Blood | 2022

von Philipp, N. | Kazerani, M. | Nicholls, A. | +22

CommentIn: Blood. 2022 Sep 8;140(10):1056-1058. - PMID 36074532

8

GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany

enthalten in: Blood | 2022

von Bethge, W. | Martus, P. | Schmitt, M. | +29

CommentIn: Blood. 2022 Jul 28;140(4):296-298. - PMID 35900785

9

GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany

enthalten in: Blood | March 22, 2022

von Bethge, W. | Martus, P. | Schmitt, M. | +29

10

2021 Update on MRD in acute myeloid leukemia : a consensus document from the European LeukemiaNet MRD Working Party

enthalten in: Blood | 2021

von Heuser, M. | Freeman, S. | Ossenkoppele, G. | +42